Enovis Corporation Share Price & Technical Analysis
ENOV · $24.19 (-1.63%)
Healthcare / Medical Devices
$24.19
-1.63%
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compress…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
3% return in May, -9% avg return in past 3 year May month.
-5% return in 2026, -16% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -19% | 16% | -7% | 3% | 3% | – | – | – | – | – | – | – | -5% |
| 25 | 6% | -16% | -3% | -8% | -10% | 0% | -14% | 17% | 0% | 3% | -3% | -13% | -40% |
| 24 | 6% | 2% | 5% | -12% | -9% | -11% | 5% | -3% | -7% | -3% | 17% | -10% | -20% |
| 23 | 16% | -8% | -7% | 9% | -9% | 22% | 1% | -12% | -7% | -13% | 9% | 14% | 13% |
| 22 | -11% | -3% | -1% | -6% | 2% | -18% | 9% | -15% | -8% | 6% | 9% | -3% | -39% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.48B
P/E ratio
—
52W high
$36.82
52W low
$21.00
Volume
7,70,511
Beta
1.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Enovis Corporation share price today?
- Enovis Corporation (ENOV) last traded around $24.19 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ENOV have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ENOV. Download the app for real-time alerts.
- How can I analyze Enovis Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.